Balance Sheet StrengthLow leverage and robust equity reduce refinancing and solvency risk, giving management flexibility to fund operations, capex, and strategic initiatives. This balance-sheet strength supports resilience through industry cycles and underpins the company's ability to pursue long-term investments without excessive debt.

Gross Margin QualityStrong gross margins indicate the company retains value from sales through efficient manufacturing and cost control. Durable gross-profitability allows Albert David to absorb pricing pressure in generics and anti-infectives, maintain investment in quality/regulatory compliance, and protect operating cash flow if revenues stabilize.

Established Formulations BusinessAn established formulations business with domestic branded/generic sales and export channels provides diversified revenue sources and market reach. This multi-channel model and focus on anti-infectives offer durable demand profiles and scalability, lowering reliance on a single market or product for growth.

Bears Say

Revenue DeclineSustained top-line contraction reduces scale benefits of manufacturing and distribution, eroding pricing power and increasing per-unit fixed costs. Continued revenue decline will pressure margins, limit reinvestment in products and markets, and could force cost reductions that impair long-term competitiveness and growth.

Earnings WeaknessA steep drop in EPS signals deteriorating profitability and possibly structural issues in margins or demand. Persistent earnings weakness weakens internal funding for R&D and capex, increases dependence on external financing, and may reflect market-share loss or adverse product-mix trends that hinder recovery.

Cash Flow StrainNegative operating cash flow and declining free cash flow constrain liquidity, forcing reliance on external funding or asset disposals. Over time this undermines the balance-sheet advantage, limits capital allocation flexibility for growth or compliance, and raises execution risk for strategic initiatives.

Albert David Ltd News

Albert David Publishes Notice on Re-Lodgement of 300 Physical Shares

Albert David Ltd ( ($IN:ALBERTDAVD) ) just unveiled an update. Albert David Ltd has disclosed that it received...

3d ago

Albert David to Close Trading Window Ahead of Q3 FY2025-26 Results

An update from Albert David Ltd ( ($IN:ALBERTDAVD) ) is now available. Albert David Limited has announced that...

3M ago

ALBERTDAVD FAQ

What was Albert David Ltd’s price range in the past 12 months?

Albert David Ltd lowest stock price was ₹642.00 and its highest was ₹959.35 in the past 12 months.

What is Albert David Ltd’s market cap?

Albert David Ltd’s market cap is ₹3.88B.

When is Albert David Ltd’s upcoming earnings report date?

Albert David Ltd’s upcoming earnings report date is May 20, 2026 which is in 65 days.

How were Albert David Ltd’s earnings last quarter?

Albert David Ltd released its earnings results on Feb 11, 2026. The company reported ₹26.815 earnings per share for the quarter, beating the consensus estimate of N/A by ₹26.815.

Is Albert David Ltd overvalued?

According to Wall Street analysts Albert David Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Albert David Ltd pay dividends?

Albert David Ltd pays a Annually dividend of ₹5 which represents an annual dividend yield of 0.66%. See more information on Albert David Ltd dividends here

What is Albert David Ltd’s EPS estimate?

Albert David Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Albert David Ltd have?

Albert David Ltd has 5,707,162 shares outstanding.

What happened to Albert David Ltd’s price movement after its last earnings report?

Albert David Ltd reported an EPS of ₹26.815 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.204%.

Which hedge fund is a major shareholder of Albert David Ltd?

Currently, no hedge funds are holding shares in IN:ALBERTDAVD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Albert David Ltd

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries. The company was incorporated in 1938 and is headquartered in Kolkata, India.